Administration of a barcoded AAV capsid library to the putamen of non-human primates identifies variants with efficient retrograde transport
Authors:
Open Access
- 10 December 2025
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 34 (3) , 1794-1812
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Knut och Alice Wallenbergs Stiftelse (KAW 2018\u20130040)
- HORIZON EUROPE Framework Programme (874758)
- VINNOVA (2020-04702)
- Vetenskapsrådet (2020\u201301684)
- Hjärnfonden
- Spark Therapeutics
- Mats Paulssons Stiftelse
- Parkinsonfonden
- Horizon 2020 Framework Programme
- F. Hoffmann-La Roche
This publication has 80 references indexed in Scilit:
- Kebilidi (eladocagene exuparvovec-tneq)Clinical Therapeutics, 2024
- AAV vectors applied to the treatment of CNS disorders: Clinical status and challengesJournal of Controlled Release, 2023
- Retrograde axonal transport property of adeno-associated virus and its possible application in futureMicrobes and Infection, 2021
- Functional parcellation of human and macaque striatum reveals human-specific connectivity in the dorsal caudateNeuroImage, 2021
- Using rAAV2-retro in rhesus macaques: Promise and caveats for circuit manipulationJournal of Neuroscience Methods, 2020
- Adeno-Associated Virus (AAV) as a Vector for Gene TherapyBioDrugs, 2017
- Membrane Dynamics and Signaling of the Coxsackievirus and Adenovirus Receptor2016
- Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double‐blind, randomized, controlled trialAnnals of Neurology, 2015
- Glial-derived neurotrophic factor gene transfer for Parkinson's disease: Anterograde distribution of AAV2 vectors in the primate brainNeurobiology of Disease, 2012
- Neurodegenerative Diseases Target Large-Scale Human Brain NetworksNeuron, 2009